Transfusion policy after severe postpartum haemorrhage: A randomised non-inferiority trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 8, 2014, Pages 1005-1014

  Prick, B W ^a,b   Jansen, A J G ^c   Steegers, E A P ^a   Hop, W C J ^a   Essink Bot, M L ^d   Uyl De Groot, C A ^e   Akerboom, B M C ^f   Van Alphen, M ^g   Bloemenkamp, K W M ^h   Boers, K E ⁱ   Bremer, H A ^j   Kwee, A ^k   Van Loon, A J ^l   Metz, G C H ^m   Papatsonis, D N M ⁿ   Van Der Post, J A M ^d   Porath, M M ^o   Rijnders, R J P ^p   Roumen, F J M E ^q   Scheepers, H C J ^r   Schippers, D H ^s   Schuitemaker, N W E ^t   Stigter, R H ^u   Woiski, M D ^v   Mol, B W J ^d   Van Rhenen, D J ^c   Duvekot, J J ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^g Flevo Hospital   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ MEDICAL CENTER HAAGLANDEN   (Netherlands)

^j Department of Obstetrics and Gynaecology Bronovo Hospital ^*  (Netherlands)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l MARTINI HOSPITAL   (Netherlands)

^m IKAZIA HOSPITAL   (Netherlands)

ⁿ AMPHIA HOSPITAL   (Netherlands)

^o MÁXIMA MEDICAL CENTER   (Netherlands)

^p JEROEN BOSCH HOSPITAL   (Netherlands)

^q Sittard Geleen Heerlen   (Netherlands)

^r MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^s CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^t DEPARTMENT OF SURGERY   (Netherlands)

^u DEVENTER HOSPITAL   (Netherlands)

^v RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Anaemia; blood transfusion; postpartum haemorrhage; quality of life

Indexed keywords

HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; COMORBIDITY; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTIDIMENSIONAL FATIGUE INVENTORY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANAEMIA; BLOOD TRANSFUSION; POSTPARTUM HAEMORRHAGE; QUALITY OF LIFE;

ADULT; ANEMIA; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, GENERAL; HOSPITALS, UNIVERSITY; HUMANS; MATERNAL WELFARE; NETHERLANDS; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84903523863     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12531     Document Type: Article

References (36)

1. World Health Organisation. WHO Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta. Geneva: WHO, 2009.
2. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM,. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008; 22: 999-1012.
3. Wang JK, Klein HG,. Red blood cell transfusion in the treatment and management of anaemia: the search for the elusive transfusion trigger. Vox Sang 2010; 98: 2-11.
4. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cll transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012; 157: 49-59.
5. Centraal Beleids Orgaan (CBO). Blood Transfusion Guideline 2011. Utrecht: CBO, 2011.
6. American Society of Anesthesiologists Task Force on Perioperative Blood T, Adjuvant T. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American society of anesthesiologists task force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006; 105: 198-208.
7. Royal College of Obstetricians and Gynaecologists (RCOG). Blood Transfusion in Obstetrics. Green Top Guidelines. London: RCOG, 2007. p.47.
8. Jansen AJG, Duvekot JJ, Essink-Bot ML, Hop WCJ, DJ vR,. Kwaliteit van leven in het kraambed en de rol van bloedverlies postpartum. Ned Tijds Obst Gynaecol 2007; 120: 18-21.
9. Jansen AJ, Duvekot JJ, Hop WC, Essink-Bot ML, Beckers EA, Karsdorp VH, et al. New insights into fatigue and health-related quality of life after delivery. Acta Obstet Gynecol Scand 2007; 86: 579-84.
10. Prick BW, Steegers EA, Jansen AJ, Hop WC, Essink-Bot ML, Peters NC, et al. Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy Childbirth 2010; 10: 83.
11. Smets EM, Garssen B, Bonke B, De Haes JC,. The Multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 315-25.
12. Jansen AJ, Essink-Bot ML, Duvekot JJ, van Rhenen DJ,. Psychometric evaluation of health-related quality of life measures in women after different types of delivery. J Psychosom Res 2007; 63: 275-81.
13. Statistics Netherlands, Definition of a Western Background. [ www.cbs.nl/ ]. Accessed May 2013.
14. Jansen AJ, Essink-Bot ML, Beckers EA, Hop WC, Schipperus MR, Van Rhenen DJ,. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes. Br J Haematol 2003; 121: 270-4.
15. Ware JE Jr,. SF-36 health survey update. Spine (Phila Pa 1976) 2000; 25 (24): 3130-9.
16. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305 (6846): 160-4.
17. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055-68.
18. Emmanuel JC,. The Clinical Use of Blood. World Health Organization Blood Safety Unit. Geneva: WHO, 2001.
19. Purcell A, Fleming J, Bennett S, Burmeister B, Haines T,. Determining the minimal clinically important difference criteria for the multidimensional fatigue inventory in a radiotherapy population. Support Care Cancer 2010; 18: 307-15.
20. Cohen J,. Statistical Power Analysis for the Behavioural Sciences. London: Academic Press, 1969.
21. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group. N Engl J Med 1999; 340: 409-17.
22. Bush RL, Pevec WC, Holcroft JW,. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. Am J Surg 1997; 174: 143-8.
23. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H,. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009; 49: 227-34.
24. Grover M, Talwalkar S, Casbard A, Boralessa H, Contreras M, Brett S, et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006; 90: 105-12.
25. Bracey AW, Radovancevic R, Riggs SA, Houston S, Cozart H, Vaughn WK, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999; 39: 1070-7.
26. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62.
27. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, McKenzie M, Alcorn KW, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT randomized pilot study). Am J Cardiol 2011; 108: 1108-11.
28. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-67.
29. Carson JL, Carless PA, Hebert PC,. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
30. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
31. Carson JL, Carless PA, Hebert PC,. Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 2013; 309: 83-4.
32. Wyrwich KW, Tierney WM, Babu AN, Kroenke K, Wolinsky FD,. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res 2005; 40: 577-91.
33. Escobar A, Quintana JM, Bilbao A, Arostegui I, Lafuente I, Vidaurreta I,. Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis Cartilage 2007; 15: 273-80.
34. Ware JE, Kosinski MA, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME,. User's Manual for the SF-36v2 Health Survey, 2nd edn. Lincoln, RI: Quality Metric Inc., 2007.
35. Rioux FM, Savoie N, Allard J,. Is there a link between postpartum anemia and discontinuation of breastfeeding? Can J Diet Pract Res 2006; 67: 72-6.
36. Barr PJ, Donnelly M, Cardwell CR, Parker M, Morris K, Bailie KE,. The appropriateness of red blood cell use and the extent of overtransfusion: right decision? Right amount? Transfusion 2011; 51: 1684-94.